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Abstract: An optical coherence tomography (OCT) for high axial 
resolution corneal imaging is presented. The system uses 375 nm bandwidth 
(625 to 1000 nm) from a broadband supercontinuum light source. The 
system was developed in free space to minimize image quality degradation 
due to dispersion. A custom-designed spectrometer based on a Czerny 
Turner configuration was implemented to achieve an imaging depth of 1 
mm. Experimentally measured axial resolution was 1.1 μm in corneal tissue 
and had a good agreement with the theoretically calculated resolution from 
the envelope of the spectral interference fringes. In vivo  imaging was 
carried out and thin corneal layers such as the tear film and the Bowman’s 
layer were quantified in normal, keratoconus, and contact lens  wearing 
eyes, indicating the system’s suitability for several ophthalmic applications. 
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1. Introduction 
Optical coherence tomography (OCT) is a leading biomedical imaging modality capable of 
generating images of living biological tissue in vivo at high resolution [1,2]. OCT has been 
widely used in the area of ophthalmology, where it has become one of the prominent 
diagnostic tools for both anterior and posterior segment of the eye [1,3–5]. Despite the 
benefits provided by OCT in studying eye diseases, origin and progression of many diseases 
are still difficult to investigate. This is due, in part, to the lack of axial resolution that enables 
us to objectively quantify certain structures in the eye. For the diseases pertaining to the 
cornea, there has been growing interest in visualizing individual corneal layers such as the 
tear film, the Bowman’s layer, and the Descemet’s membrane. However, the thickness of 
these layers can be as thin as 3–15 μm [6], which makes it difficult to image them reliably in 
vivo.  In vivo  confocal microscopy offers optical sectioning capability at cellular level 
resolution [7,8]. Mostly though, its limited field  of view, resulting from high image 
magnification, makes it difficult to acquire wide area corneal images. Although OCT can 
overcome this limitation at the cost of lateral resolution, standard anterior segment OCT 
systems do not have sufficient axial resolution to precisely quantify the thickness of all the 
individual corneal layers. Hence, it has been increasingly important to further improve the 
axial resolution of the OCT for these applications. 
With the advances in broadband light sources, images with axial resolution of a few 
microns have been obtained using OCT for both the posterior segment [9,10] and the anterior 
segment [11] of the eye. The high resolution anterior segment OCT can now directly visualize 
individual corneal layers like the Bowman’s layer and the Descemet’s membrane in vivo and 
has been used in studying the changes in these layers resulting from Fuch’s Dystrophy [12] 
and hypoxia induced corneal swelling [13]. OCT has also been used in indirect tear film 
thickness measurement [14,15]. The axial resolution of the OCT systems used in these studies 
was 3–4 μm, which is just two to five times smaller than the structures been studied [6]. This 
may cause an increase in measurement variability and errors. Moreover, it has not been 
possible to directly visualize the natural tear film over the human cornea that is estimated to 
be 2–5 μm by interferometric methods [16]. 
Our goal in this study is to develop a corneal OCT with one micrometer axial resolution, 
which could be used to quantify thickness profiles of the tear film and thin corneal layers in 
both normal and pathological corneas. The axial resolution of OCT is inversely proportional 
to the bandwidth and proportional to the square of the center wavelength of the light source 
[17]. Using small center wavelength for in vivo human eye imaging could be hazardous [18] 
and lead to patient discomfort, we hence used a broad bandwidth light (375 nm) from a 
supercontinuum source centered at 812.5 nm to achieve ultrahigh axial resolution. While sub-
micrometer axial resolution in OCT systems has been achieved using broad bandwidth 
femtosecond or supercontinuum lasers with bandwidths larger than 350 nm [19–21], these 
systems were time domain systems. Fourier domain OCT systems [2,22] provide improved 
sensitivity and imaging speed compared to time domain systems [23–25]. Using bandwidths 
larger than 350 nm in Fourier domain systems however has been difficult and to the best of 
our knowledge has not been reported to date. The challenge is to design spectrometers having 
a large spectral range along with high spectral resolution required for acceptable imaging 
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configuration that has been proposed by our group [26]. System design and imaging 
performance of the proposed OCT will be discussed in detail in this paper and potential 
ophthalmic applications are presented. 
2. System design 
2.1. Spectrometer 
The cornea is a curved surface with an average radius of curvature of 7.8 mm [27]. To image 
a 4 mm wide lateral section around the apex of the cornea, an imaging depth of at least 1 mm 
is required. The imaging depth of spectral domain OCT is directly proportional to the 
resolving power of the spectrometer. Thus, to achieve the required imaging depth, designing a 
spectrometer with high spectral resolution and wide spectral range is crucial. Czerny Turner 
spectrometers have been used for applications where high spectral resolution and large 
spectral range are required [28–30]. Benefits of this design are that it is corrected for coma 
while spherical aberration is minimized by keeping the numerical aperture low. Astigmatism 
however is left uncorrected. This design works well in a traditional spectrometer where slits 
are used since spot elongation caused by astigmatism occurs along the direction of the slit, 
resulting in negligible power loss. In our application, where a linescan camera is used, the 
power loss is substantial due to the small pixel size (5 × 5 μm
2), leading to a reduction in 
signal to noise ratio. Recently, the design of a low cost spectrometer based on a Czerny 
Turner configuration has been demonstrated where astigmatism is corrected using a 
cylindrical lens placed before the detector [26]. An equivalent geometry spectrometer was 
designed and assembled for this study based on a different light source and detector. 






δλ =    (1) 
where d is the imaging depth, λ is the wavelength and δλ is the spectral resolution. The 
spectral resolution requirement, as calculated from Eq. (1), changes from 0.096 nm at 625 nm 
to 0.250 nm at 1000 nm for 1 mm imaging depth. Assuming the spectral resolution 
requirement to be 0.096 nm and the spectral range to be 375 nm, the spectral data must be 
sampled over at least 3907 points (i.e. 375 nm/0.096 nm). We hence used an 8160 pixel 
linescan camera (L803K, Basler), sampling the signal over all of its 8160 pixels. The system 
thus, should be limited by the spectral resolution obtained by the spectrometer optics. 
 
Fig. 1. The spectrometer PSF for two wavelengths separated by the required spectral resolution 
calculated from Eq. (1) for (a) 625 nm (b) 700 nm (c) 800 nm (d) 900 nm (e) 1000 nm. 
Ray tracing software CODE V (Synopsys Inc) was used to evaluate the spectral resolution 
at five wavelengths (625 nm, 700 nm, 800 nm, 900 nm and 1000 nm) wherein the 
spectrometer is defined to have just two discrete wavelengths that are separated by the 
required spectral resolution at that wavelength and the PSF of the system was calculated. 
Figure 1  shows the PSFs obtained, while Fig. 2  shows the plot comparing the required 
spectral resolution obtained by Eq. (1) with the actual spectral resolution of the optics. Ideally 
the actual spectral resolution should be smaller than the required spectral resolution for all 
wavelengths. We note that the spectrometer meets the resolution requirement for all the 
wavelengths except around 600 nm. The lack of spectral resolution in some wavelength band 
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will lead to a reduction in the axial resolution. The system hence satisfies the criteria of 
imaging depth larger than 1 mm, though the effective bandwidth of the system is reduced to 
300 nm at 1mm imaging depth, which yields a reduced axial resolution. 
 
Fig. 2. Spectral resolution predicted by ray tracing compared with the required spectral 
resolution. The spectral resolution requirement is satisfied by all wavelengths except between 
625 nm and 690 nm. 
2.2. Optical system layout 
The OCT was built in free space to avoid reduction in axial resolution due to dispersion 
induced by the optical fiber [31–33] and because of the lack of a readily available fiber optic 
directional coupler for such a broad bandwidth light source. 
Figure 3 shows the schematic of the OCT system. A near IR achromatic doublet lens 
(Thorlabs, focal length = 35 mm, diameter = 25.4 mm) collimates the beam from the 
supercontinuum source (Leukos, SM-20) and a bandpass filter, which is a combination of a 
long pass (Semrock, model # BLP01-561R-25) and a short pass filter (Omega Optical, model 
# 3RD1000SP), is used to select the spectrum from 625 nm to 1000 nm. The beam diameter 
was 6 mm and is controlled by an adjustable diaphragm. The beam is then split into the 
sample and reference arm by a 50/50 cube beamsplitter (Edmund Optics). In the sample arm, 
the beam is scanned on the sample in telecentric geometry using a galvanometer based optical 
scanner (Cambridge Technologies, model # 6220) and is focused by an objective lens (focal 
length = 60 mm, working distance = 56 mm, diameter = 25.4 mm) which has two achromatic 
doublets with focal lengths 100 mm and 150 mm (Thorlabs) separated by 5 mm. In the 
reference arm, an identical objective lens is used to focus the beam on the reference mirror in  
 
 
Fig. 3. Full schematic of the OCT system. C,  Collimator;  BF,  Bandpass filter;  BS, 
Beamsplitter; VND, Variable neutral density filter; SM, Scanning mirror; OL, Objective lens; 
S, Sample; M, Reference mirror; FL, Focusing lens; CM1, First concave mirror; G, Linear 
grating; CM2, Second concave mirror; CL, Cylindrical lens; D, Linescan CCD. 
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(Thorlabs) was placed in the reference arm to maximize the fringe visibility. To match 
dispersion, an identical V-NDF set at maximum transmission (OD = 0) was placed in the 
sample arm. 
Two beams traveling back from the sample and reference arms are focused to enter the 
spectrometer using the same lens as the objective. On entering the spectrometer the beam is 
collimated by a concave mirror (Edmund Optics, focal length = 200 mm and diameter = 50.8 
mm). A diffraction grating (Richardson gratings, 500 grooves/mm) disperses the collimated 
beam into its wavelength components. These different wavelengths are then focused onto the 
linescan camera using another concave mirror identical to the first one and an astigmatism 
correcting cylindrical lens (Thorlabs, focal length = 100 mm). The raw data, through a frame 
grabber (Bitflow Inc., Karbon CL), is transferred to a workstation (Dell, Precision 7400). 
2.3. k-space remapping and dispersion compensation 
To accurately sample the OCT signal linearly in k-space, we calibrated the spectrometer 
experimentally. We first theoretically evaluated the positions of 41 different wavelengths 
between 600 nm and 1000 nm at 10 nm step on the linescan camera using CODE V. The 
positions of four different wavelengths (633 nm, 700 nm, 830 nm and 976 nm) were then 
measured on the linescan camera by placing laser line filters in the beam path. The 
theoretically obtained spectral positions were then linearly scaled and translated to match the 
experimentally measured positions to account for tolerances in components and alignment 
associated with building the system. The 41 data points were then interpolated to 8160 sample 
points, providing equispaced data sampling in k-space. 
Although the dispersion between the reference and sample arm was matched by using 
identical optics in both the arms, for such a large bandwidth, even a small dispersion 
mismatch can cause reduction in system performance. Hence, numerical dispersion 
compensation [10] was implemented to achieve optimal performance. 
3. System performance 
3.1. Axial and lateral resolution and depth sensitivity 
The axial resolution of the OCT system was estimated by replacing the sample with a flat 
mirror. To ensure that there is no degradation in the axial resolution due to errors in k-space 
remapping and dispersion mismatch, theoretical axial point spread function (PSF) was 
calculated as the Fourier transform of the envelope of the spectral interference fringes. Figure 
4(a) shows the measured axial PSF at the axial distance of 0.16 mm in blue and the theoretical 
axial PSF in dashed red. The axial resolution, estimated as the full width at half maximum  
 
 
Fig. 4. (a) The axial PSF of the OCT measured experimentally by a mirror in the sample arm 
shown  in blue, the PSF estimated theoretically from the envelope of spectral interference 
fringes shown in dashed red. The FWHM of the axial PSF is estimated to be 1.52 μm in air 
which corresponds to 1.11 μm in corneal tissue. (b) Sensitivity roll off of the system evaluated 
by measuring the axial PSF at different depths. 
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= 1.376) [6]. The FWHM of the theoretical axial PSF was 1.45 μm in air and is in good 
agreement with that from the measured PSF, indicating that the system achieves optimal axial 
resolution. The lateral resolution of the OCT, defined as the focal spot size on the sample, was 
measured to be 25 μm on a CCD, which was 1.25 times the diffraction limited spot size of 20 
μm. 
Figure 4(b) shows the axial PSF of the OCT system plotted at seven axial locations up to 
1.1 mm. A 21 dB roll off in the sensitivity of OCT from 0.16 mm to 1 mm depth was 
observed. An axial resolution of 1.11 μm was maintained up to the depth of 0.32 mm beyond 
which it starts to degrade with depth and is estimated to be 3.0 μm in tissue at the depth of 1 
mm. The degradation in sensitivity and axial resolution is due to limited spectral resolution of 
the spectrometer. 
3.2. Validation of thickness measurements with the OCT 
To validate the accuracy of the OCT system in estimating thickness, four reference samples 
(photoresist spin coated on top of a silica chip) with known thicknesses were fabricated. The 
refractive index and thickness of the samples were measured using an ellipsometer with 
refractive index estimated to be 1.61 and thicknesses values being 0.91 μm, 1.36 μm, 3.37 μm 
and 4.40 μm. The images obtained for the samples are shown in Fig. 5. Since the thickness 
values are close to the axial resolution of the OCT, the images were obtained after zero 
padding the interference signal to reduce the pixel separation by five times. The two interfaces 
can  be  distinctively  identified  in  all  the  samples  except  the  0.91  μm  thick  sample.  The 
photoresist thicknesses measured by OCT were 1.25 ± 0.13 μm, 3.45 ± 0.05 μm and 4.58 ± 
0.06 μm,  obtained  from  five independent measures along the surface of the sample. The 
ellipsometry and the OCT measurements differ due to limited accuracy of the OCT measures 
(0.1 μm). 
 
Fig. 5. The images obtained for the photoresists (n = 1.6) of thickness (a) 0.91 μm (b) 1.36 μm 
(c) 3.37 μm and (d) 4.40 μm and the peaks for photoresist thickness of (e) 0.91 μm (f) 1.36 μm 
(g) 3.37 μm and (h) 4.40 μm. 
3.3. Imaging the human cornea and ophthalmic applications 
In vivo OCT imaging was performed on human corneas. The research adhered to the tenets of 
the Declaration of Helsinki. The protocol was approved by the Research Subjects Review 
Board at the University of Rochester. Informed consent was obtained from all participants 
after the purpose of the study and the procedures were explained. The power of the light 
shined into the subject’s eye was 0.75 mW, which is 80 times below the maximum 
permissible exposure as dictated by ANSI [29]. A bite bar was used to minimize the subject’s 
head motion. Each image consists of 250 A-scans. Exposure time for each A-scan was 1 ms 
and the real time frame rate obtained on the screen was 2 frames/s. Such a large exposure time 
is used because it is difficult to focus all the light coming from the sample arm of the OCT on 
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2). Further improvement in the spectrometer 
design is required to improve the frame rate. 
Figure 6 shows the image obtained by the system for a 4 mm section around the apex of a 
normal cornea. The thin topmost layer in the image is the tear layer whose mean thickness 
across the 4 mm section was measured to be 4.7 ± 1.6 μm. The next two layers, epithelium 
and Bowman's layer, had mean thicknesses of 49.7 ± 1.4 μm and 19.2 ± 1.2 μm, respectively. 
The Bowman's layer is followed by the stroma, which is made up of brightly reflecting 
centers that may be keratocytes. Below the stroma is the Descemet's membrane followed by 
the endothelium. The Descemet's membrane can be visualized as a thin strip in the lower 
portion  of  the  cornea.  The  thickness  of  this  layer  was  measured  to  be  4  ±  0.7  μm.  The 
endothelium can be visualized as the last bright boundary of the cornea. In these thickness 
estimates, we assumed the refractive index of 1.401 for the epithelium [34] and an average 
corneal refractive index of 1.376 for Bowman's layer and Descemet’s membrane [6]. 
To demonstrate the capability of the OCT system in studying ocular pathologies we also 
imaged abnormal corneas. 
 
Fig. 6. OCT image of the cornea of a normal patient. TL: Tear Layer, EP: Epithelium, BL: 
Bowman’s Layer, SR: Stroma, DM: Descemet’s Membrane, EN: Endothelium. 
3.3.1. Keratoconus 
Keratoconus is a degenerative disorder of the eye that involves non-inflammatory thinning 
and steepening of the central and/or para-central cornea [35]. Although the exact cause of 
keratoconus is uncertain, the evidence suggests that the corneal epithelium and Bowman’s 
layer may be involved in the disease development [36–40]. 
Micrometer resolution OCT was used to image individual corneal layers of moderate and 
severe keratoconus patients as shown in Fig. 7(b) and (c). A normal cornea (Fig. 7(a)) was 
also included for comparison. The center thickness, averaged over three repeated 
measurements on the same image, in normal cornea (464.7 ± 0.8 μm) was significantly larger 
than keratoconus corneas (moderate: 408.1 ± 1.8 μm and severe: 404.5 ± 0.4 μm) with it 
being smallest in severe case. A similar trend of decrease in thickness with severity of disease  
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Fig. 7. OCT images of (a) Normal (same image shown in Fig. 6), (b) moderate keratoconus (c) 
severe keratoconus. 
 
Fig. 8.  (a) Image of the contact lens wearer's cornea immediately after instilling a tear drop, 
where the subject was wearing the contact lens for three minutes. (b) Zoom-in view of the 
PLTF: two interfaces can be clearly visualized. (c) Zoom-in view of the PoLTF: two interfaces 
are distinguishable. 
was observed for both the epithelium and the Bowman’s layer with successive reduction in 
mean epithelium thickness being observed from normal (49.7 ± 1.4 μm) to moderate (43.8 ± 
2.2 μm) to severe (35.8 ± 11.7 μm) keratoconus and mean Bowman’s layer thickness being 
larger in normal cornea (19.2 ± 1.2 μm) than moderate keratoconus cornea (14.8 ± 1.2 μm). In 
severe keratoconus subject the Bowman’s layer could not be observed, indicating the potential 
destruction of the Bowman’s layer in this case. 
Steepening of the cornea was observed with increased disease severity wherein the 
anterior corneal surface was flattest for normal cornea (Radius of curvature averaged over 
three measurements on the same image or R = 10.5 ± 0.3 mm) and the steepness increasing 
from moderate (R = 8.3 ± 0.2 mm) to severe keratoconus cornea (R = 7.4 ± 0.2 mm). A 
significant increase in the amount of light backscattered from the Bowman’s layer can be 
observed in a moderately keratoconus cornea when compared with a normal cornea. 
3.3.2. Tear Layers associated with soft contact lens 
It has been estimated that more than half of the contact lens wearers experience ocular dryness 
and discomfort [41,42]. Pre lens tear film (PLTF) and post lens tear film (PoLTF) play a vital 
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understand the safety and comfort of contact lenses, determining the thickness of PLTF and 
PoLTF is crucial. Figure 8(a) shows the image taken immediately after instilling the tear drop 
on the subject who was wearing the contact lens for three minutes. Figures 8(b) and (c) show 
the zoom-in view of the PLTF and PoLTF, respectively wherein the two interfaces can be 
visualized in both cases. The average thickness of PLTF and PoLTF were calculated to be 6.8 
± 1.1 μm and 2.9 ± 1.2 μm, respectively. 
4. Conclusions 
This study demonstrates a micrometer-resolution spectral domain OCT with a custom 
developed astigmatism corrected spectrometer based on Czerny Turner design. The axial 
resolution  of  1.11  μm  in  corneal  tissue  was  achieved  with  the  thickness  measurement 
accuracy verified using photoresist layer samples. In vivo human corneal imaging was carried 
out that indicates the feasibility of quantifying the thickness of the individual corneal layers 
including the tear film, the Bowman’s layer, the Descemet’s membrane and the epithelium. 
Micrometer resolution OCT can be a powerful tool enabling us to improve our knowledge of 
the etiology and progression of corneal and ocular surface diseases. 
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